alexa Genetic Polymorphisms And Outcome Research In Cancer: Examples From Angiogenesis And Metastasis Genes And Colorectal Cancer
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics
November 03-05, 2014 Embassy Suites Las Vegas, USA

Sevtap Savas, Lydia A Dan, Jingxiong Xu, Salem Werdyani, Konstantin Shestopaloff, Elizabeth Dicks, Patrick Parfrey, Roger Green and Wei Xu
Accepted Abstracts: J Pharmacogenomics Pharmacoproteomics
DOI: 10.4172/2153-0645.S1.004
Colorectal cancer is a common disease worldwide. Understanding the biology behind the risk of disease outcomes is essential for both the clinical management and the development of new therapeutics. For this purpose, genetic variations (e.g. polymorphisms) and their associations with disease outcomes in patients (e.g. as recurrence) are actively investigated in colorectal cancer. Investigating the genetic polymorphisms as variables in outcome research requires a number of considerations, which are not typical of other variables (e.g. stage). For instance, since the effect of a polymorphism on survival outcomes may differ from one genotype to another, using an appropriate genetic model (recessive, dominant, co-dominant or additive) during the statistical analysis is a critical consideration. We previously suggested a way to estimate the best genetic model for individual polymorphisms based on the separation of the Kaplan Meier curves of patient groups with different genotypes. Our team, including the investigators from the Newfoundland Colorectal Cancer Registry (NFCCR), has applied this strategy to 381 polymorphisms in 30 genes from the angiogenesis and metastasis pathways in a cohort of 505 Caucasian colorectal cancer patients recruited to the NFCCR. As a result, we have found several polymorphisms on chromosome 11 as being associated with the risk of death in our patient cohort.
Sevtap Savas obtained her PhD in Molecular Biology and Genetics in 1999 from the Bogazici University, Turkey. She was trained as a Post-doctoral fellow or Research Associate in Louisiana State University (USA), Mount Sinai Hospital Research Institute (Canada) and Princess Margaret Hospital/Ontario Cancer Institute (Canada). Since 2008 she has been an Assistant Professor at Discipline of Genetics, Memorial University of Newfoundland (Canada). Her research program currently focuses on genetic prognostic studies in colorectal cancer using genetic, epidemiological, biostatistical and computational approaches and development of public databases. She also serves as a reviewer, academic editor or editorial board member for several journals.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version